Skip to main content
OpenTrials
Completed

NCT Number: NCT05047146

The Clinicopathological and Prognostic Factors of Hepatocellular Carcinoma; 10 Years' Tertiary Center Experience in Egypt

This study aimed at study the clinical and pathological criteria of Hepatocellular carcinoma to keep with new challenging in diagnosis and morpho-molecular classifications

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hepatocellular Carcinoma Adenocarcinoma Carcinoma Carcinoma, Hepatocellular Digestive System Diseases Digestive System Neoplasms Liver Diseases Liver Neoplasms Neoplasms Neoplasms by Histologic Type Neoplasms by Site Neoplasms, Glandular and Epithelial

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

National Liver Intitute

Shibīn al Kawm, Menoufia, 32511, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All pathologically proven Hepatocellular Carcinoma

Exclusion criteria

  • Other malignant tumors than Hepatocellular Carcinoma
  • Benign tumor

Treatment and study plan

Morphological classifications of HCC

Other

Morphological classifications of Hepatocellular carcinoma

Primary outcomes

  1. Clinicopathological factors of Hepatocellular Carcinoma

    Time frame: 10 years

    Serum alpha-fetoprotein (AFP) level

  2. Clinicopathological factors of Hepatocellular Carcinoma

    Time frame: 10 years

    Tumor size and focality

  3. Clinicopathological factors of Hepatocellular Carcinoma

    Time frame: 10 years

    Vascular invasion

  4. Clinicopathological factors of Hepatocellular Carcinoma

    Time frame: 10 years

    Pathologic stage and grade

  5. Clinicopathological factors of Hepatocellular Carcinoma

    Time frame: 10 years

    The reserve of background liver

Sponsors and collaborators

Lead sponsor

Sadat City University

Other

Registry information

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Sep 16, 2021
Registry last updated
Oct 25, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.